AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Stef Group

Remuneration Information Jun 10, 2019

1686_dirs_2019-06-10_0e17f643-9977-498d-8dc9-61cc819646ba.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7254B

Stenprop Limited

10 June 2019

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP    JSE share code: STP

ISIN:  GG00BFWMR296

("Stenprop" or the "Company")

DEALINGS IN SECURITIES BY DIRECTORS, BY A DIRECTOR OF MAJOR SUBSIDIARIES OF THE COMPANY AND

BY THE COMPANY SECRETARY

10 June 2019

Shareholders are advised of the following information relating to the acceptance of nil cost options and market value options awarded on 6 June 2019 under the Stenprop Limited Long Term Incentive Plan ("Long Term Incentive Plan"). The nil cost options will vest on 31 March 2022 subject to certain vesting conditions having been met, including performance targets set by the remuneration committee prior to the awards being made. Assuming that the performance targets are met in full at the end of the performance period, the nil cost options will result in the issue of 964,172 shares. The market value options will vest in three tranches on 31 March 2020, 31 March 2021 and 31 March 2022 and once fully vested will result in the issue of 320,063 shares subject to the payment of the exercise price of £1.1171 per share.

Name of director: Paul Arenson
Transaction date: 6 June 2019
Class of securities: Nil cost options
Number of securities: 491,631
Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:
Off-market acceptance of nil cost options in terms of the Long Term Incentive Plan

Direct beneficial

Yes
Name of director: Julian Carey
Transaction date: 6 June 2019
Class of securities: Nil cost options
Number of securities: 472,541
Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:
Off-market acceptance of nil cost options in terms of the Long Term Incentive Plan

Direct beneficial

Yes
Name of director: James Beaumont
Transaction date: 6 June 2019
Class of securities: Market value options
Number of securities: 109,361
Total price payable on exercise: £122,167.17
Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:
Off-market acceptance of market value options in terms of the Long Term Incentive Plan

Direct beneficial

Yes
Name of director: Neil Marais
Name of major subsidiaries: Stenprop (UK) Limited and Stenprop (Germany) Limited
Transaction date: 6 June 2019
Class of securities: Market value options
Number of securities: 94,627
Total price payable on exercise: £105,707.82
Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:
Off-market acceptance of market value options in terms of the Long Term Incentive Plan

Direct beneficial

Yes
Name of company secretary: Sarah Bellilchi
Transaction date: 6 June 2019
Class of securities: Market value options
Number of securities: 116,075
Total price payable on exercise: £129,667.38
Nature of transaction:

Nature and extent of company secretary's interest:

Clearance to deal received:
Off-market acceptance of market value options in terms of the Long Term Incentive Plan

Direct beneficial

Yes

Shareholders are further advised of the following information relating to the acceptance of nil cost options awarded on 6 June 2019 under the Stenprop Limited Amended Deferred Share Bonus Plan ("Deferred Bonus Plan"). One third of these nil cost options vested immediately, with the second third vesting on 31 March 2020 and the last third vesting on 31 March 2021. Once fully vested, they will result in the issue of 478,296 shares.

Name of director: Paul Arenson
Transaction date: 6 June 2019
Class of securities: Nil cost options
Number of securities: 142,137
Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:
Off-market acceptance of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes
Name of director: Patsy Watson
Transaction date: 6 June 2019
Class of securities: Nil cost options
Number of securities: 136,618
Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:
Off-market acceptance of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes
Name of director: Julian Carey
Transaction date: 6 June 2019
Class of securities: Nil cost options
Number of securities: 136,618
Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:
Off-market acceptance of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes
Name of director: James Beaumont
Transaction date: 6 June 2019
Class of securities: Nil cost options
Number of securities: 21,112
Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:
Off-market acceptance of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes
Name of director: Neil Marais
Name of major subsidiaries: Stenprop (UK) Limited and Stenprop (Germany) Limited
Transaction date: 6 June 2019
Class of securities: Nil cost options
Number of securities: 17,347
Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:
Off-market acceptance of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes
Name of company secretary: Sarah Bellilchi
Transaction date: 6 June 2019
Class of securities: Nil cost options
Number of securities: 24,469
Nature of transaction:

Nature and extent of company secretary's interest:

Clearance to deal received:
Off-market acceptance of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes

For further information:

Stenprop Limited                                                                                              +44(0)20 3918 6600

Paul Arenson

Julian Carey

James Beaumont

Numis Securities Limited (Financial Adviser)                                             +44(0)20 7260 1000

Hugh Jonathan

Vicki Paine     

Tavistock (PR Adviser)                                                                                     +44(0)20 7920 3150

James Whitmore

James Verstringhe

Charlotte Dale

Java Capital                                                                                                       +27 (0)11 722 3050

(JSE sponsor)

About Stenprop:

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHCKKDQQBKDDAD

Talk to a Data Expert

Have a question? We'll get back to you promptly.